Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07102797 · ClinicalTrials.gov registry record · NA

ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence

A NA study of Physical Activity and Insulin Resistance, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07102797: Recruiting NA study of Physical Activity and Insulin Resistance, sponsored by Massachusetts General Hospital.

NCT07102797 is a NA study of Physical Activity and Insulin Resistance that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07102797, a NA study of Physical Activity and Insulin Resistance, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study explores how a physical activity program can affect hormone health and diabetes risk in girls ages 8-12 who may be at higher risk. The study aims to address: * Does the 'ActiveGirls' program meet the needs of girls and families in engaging them to increase physical activity? * What is the trend of markers of diabetes risk and puberty hormones over a 1-year period and how are these levels related to physical activity levels? Participants in this study will either: * Participate in a 'full' intensity intervention that includes educational messages (text/email) as well as health coaching visits to support physical activity over a 6 month period * Participate in a delayed 'lower intensity' intervention that includes only educational messages (text/email) * Participants in both groups will complete at-home activity monitoring, two study visits for check-ups and tests, and surveys

Primary Outcome

Proportion of participants completing each study assessment point/coaching visit divided by total participants enrolled/eligible

Conditions Studied

Physical Activity Insulin Resistance Puberty PCOS (Polycystic Ovary Syndrome)

Interventions

  • BEHAVIORAL ActiveGirls Physical Activity Program (Full)
  • BEHAVIORAL ActiveGirls Physical Activity Program (Delayed Lower Intensity)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Somerville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-11-24
Est. Completion 2027-12
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT07102797 shows while recruiting

NCT07102797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (89% lower).

The record links to 4 conditions, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which ActiveGirls Physical Activity Program (Full) is the first listed.

NCT07102797 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07102797 about?

NCT07102797 is a clinical study titled "ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence". This study explores how a physical activity program can affect hormone health and diabetes risk in girls ages 8-12 who may be at higher risk. The study aims to address: * Does the 'ActiveGirls' program meet the needs of girls and families in engaging them to increase physical activity? * What is th...

What is the current status of trial NCT07102797?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-24. Estimated completion is 2027-12.

What conditions does trial NCT07102797 study?

This clinical trial studies the following conditions: Physical Activity, Insulin Resistance, Puberty, PCOS (Polycystic Ovary Syndrome).

What interventions are being tested in trial NCT07102797?

The interventions under investigation include: ActiveGirls Physical Activity Program (Full) (BEHAVIORAL), ActiveGirls Physical Activity Program (Delayed Lower Intensity) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07102797?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07102797 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07102797's enrollment target sits among peer trials

40 103rd of 131 higher than 23 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07102797

Source: ClinicalTrials.gov NCT07102797, the US trial registry maintained by the National Library of Medicine. NCT07102797 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.